NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
National Institutes of Health · National Center on Sleep Disorders Research (93.233)
Опубликован 5 дек. 2024 г. · Осталось примерно 3 месяца
Простыми словами
Краткое описание на русском пока недоступно; показано на английском.
The US National Institutes of Health funds phase I clinical trials for diagnostic and therapeutic interventions targeting heart, lung, blood, and sleep disorders in adults and children. Grants up to 1.515 million US dollars support US-based academic institutions, nonprofits, companies, and government bodies, with applications due by 7 January 2027.
Автоматическое краткое изложение текста донора; оригинальная формулировка приведена ниже.
Краткое описание
Исходный текст донора (английский)
The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite.
Applicants applying for funding under this NOFO should be ready to initiate the clinical trial within the first quarter of the project period. Discussion, submission, and attainment of applicable regulatory (FDA, DSMB, IRB) approvals, and establishment of drug (and placebo, if applicable) supplies, and any necessary third-party agreements should be established by the time of award. If time and support for these and other pre-clinical and/or trial readiness activities are desired, applicants should consider the companion NOFO which utilizes an R61/R33 phased approach.
Фрагмент со страницы донора. Полный текст, приложения и формы — в исходном объявлении о конкурсе.
Кто может подать заявку
- Академическое или исследовательское учреждение
- Частная компания
- НКО / гражданское общество
- Государственный орган
Требования и условия
Показать требования из источника · Исходный текст донора (английский)
Applicant types: Private institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Public housing authorities/Indian housing authorities; For profit organizations other than small businesses; Small businesses; State governments; Special district governments; Others (see text field entitled "Additional Information on Eligibility" for clarification); Independent school districts; Native American tribal organizations (other than Federally recognized tribal governments); Native American tribal governments (Federally recognized); Public and State controlled institutions of higher education; County governments; City or township governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.